ENZIDE
Main information
- Trade name:
- ENZIDE 10 TAB
- Active ingredient:
- Enalapril Maleate,Hydrochlorthiazide
- Available from:
- Cadila Ph.
- Dosage:
- 10,25;MG
- Pharmaceutical form:
- TAB
- Composition:
- 10
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
31-8-2018

Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Revision: 18, Authorised
Europe - EMA - European Medicines Agency
1-8-2018

Veterinary medicine European public assessment report (EPAR): Apoquel, oclacitinib maleate, Revision: 4, Authorised
Europe - EMA - European Medicines Agency
18-2-2019

Pholcodine / biclotymol / chlorphenamine maleate : List of nationally authorised medicinal products - PSUSA/00010437201804
Pholcodine / biclotymol / chlorphenamine maleate : List of nationally authorised medicinal products - PSUSA/00010437201804
Europe - EMA - European Medicines Agency
19-12-2018

Enalapril: List of nationally authorised medicinal products - PSUSA/00001211/201803
Enalapril: List of nationally authorised medicinal products - PSUSA/00001211/201803
Europe - EMA - European Medicines Agency
28-11-2018

Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018
Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018
Europe - EMA - European Medicines Agency
21-11-2018

EU/3/17/1923 (Pfizer Europe MA EEIG)
EU/3/17/1923 (Active substance: Glasdegib maleate) - Transfer of orphan designation - Commission Decision (2018)7839 of Wed, 21 Nov 2018 European Medicines Agency (EMA) procedure number: EMA/OD/106/17/T/01
Europe -DG Health and Food Safety
10-9-2018

Enalapril / nitrendipine: List of nationally authorised medicinal products - PSUSA/00001213/201801
Europe - EMA - European Medicines Agency
30-7-2018

Apoquel (Zoetis Belgium S.A.)
Apoquel (Active substance: Oclacitinib maleate) - Centralised - Renewal - Commission Decision (2018)5153 of Mon, 30 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2688/R/13
Europe -DG Health and Food Safety